Terms: = Head and neck cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
191 results:
1. Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and hmga2.
Ma D; Chen J; Shi Y; Gao H; Wei Z; Fan J; Wang L
Sci Rep; 2024 Apr; 14(1):9616. PubMed ID: 38671227
[TBL] [Abstract] [Full Text] [Related]
2. Proceedings of the 2024 North American Society of head and neck Pathology Companion Meeting, Baltimore, MD, March 24, 2024: Navigating Ancillary Studies in Basaloid/Blue Salivary Tumors.
Wong KS
Head Neck Pathol; 2024 Mar; 18(1):24. PubMed ID: 38526755
[TBL] [Abstract] [Full Text] [Related]
3. Mechanisms Involved in Therapeutic Effects of
Bayat Z; Mazaheri T; Farhadifard H; Taherkhani A
Biomed Res Int; 2024; 2024():1236910. PubMed ID: 38322303
[TBL] [Abstract] [Full Text] [Related]
4. SOX10-Internal Tandem Duplications and PLAG1 or hmga2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors.
Macagno N; Kervarrec T; Thanguturi S; Sohier P; Pissaloux D; Mescam L; Jullie ML; Frouin E; Osio A; Faisant M; Le Loarer F; Cribier B; Calonje E; Luna EVE; Massi D; Goto K; Nishida H; Paindavoine S; Houlier A; Tantot J; Benzerdjeb N; Tirode F; De la Fouchardière A; Battistella M
Mod Pathol; 2024 Mar; 37(3):100430. PubMed ID: 38266920
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/hmga2 expression.
Zeng Z; Tang S; Chen L; Hou H; Liu Y; Li J
Aging (Albany NY); 2023 Dec; 15(24):14930-14944. PubMed ID: 38112616
[TBL] [Abstract] [Full Text] [Related]
6. LINC02454 promotes thyroid carcinoma progression via upregulating hmga2 through CREB1.
Cao Y; Li J; Du Y; Sun Y; Liu L; Fang H; Liang Y; Mao S
FASEB J; 2023 Dec; 37(12):e23288. PubMed ID: 37997502
[TBL] [Abstract] [Full Text] [Related]
7. Expanding the histological spectrum of salivary gland neoplasms with hmga2::WIF1 fusion emphasising their malignant potential: a report of eight cases.
Katabi N; Sukhadia P; DiNapoli SE; Weinreb I; Hahn E; Ghossein R; Xu B
Histopathology; 2024 Jan; 84(2):387-398. PubMed ID: 37849332
[TBL] [Abstract] [Full Text] [Related]
8. CRISPR/Cas9-mediated high-mobility group A2 knockout inhibits cell proliferation and invasion in papillary thyroid carcinoma cells.
Jin S; Yong H; Liu Y; Bao W
Adv Med Sci; 2023 Sep; 68(2):409-416. PubMed ID: 37837800
[TBL] [Abstract] [Full Text] [Related]
9. C2orf48 promotes the progression of nasopharyngeal carcinoma by regulating high mobility group AT-hook 2.
Jiang Y; Liang F; Chen R; Huang Y; Xiao Z; Zeng H; Han P; Huang X
Med Oncol; 2023 Sep; 40(11):306. PubMed ID: 37755629
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
Key S; Chia C; Hasan Z; Sundaresan P; Riffat F; Dwivedi RC
Laryngoscope; 2024 Mar; 134(3):1042-1053. PubMed ID: 37610148
[TBL] [Abstract] [Full Text] [Related]
11. [Fibrocartilaginous lipoma: a clinicopathological analysis of six cases].
Li HL; Wang J; Cheng H; Zhang SJ; Mao RJ
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):827-831. PubMed ID: 37527988
[No Abstract] [Full Text] [Related]
12. Unraveling the Roles of miR-204-5p and hmga2 in Papillary Thyroid cancer Tumorigenesis.
Van Branteghem C; Augenlicht A; Demetter P; Craciun L; Maenhaut C
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445942
[TBL] [Abstract] [Full Text] [Related]
13. Localized delivery of Erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinoma.
Hariharan K; Mehta T; Shah J; Dave H; Sami A; Omri A
Int J Pharm; 2023 Jul; 642():123144. PubMed ID: 37330155
[TBL] [Abstract] [Full Text] [Related]
14. Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated hmga2 transcription.
Yang Z; Liu F; Li Z; Liu N; Yao X; Zhou Y; Zhang L; Jiang P; Liu H; Kong L; Lang C; Xu X; Jia J; Nakajima T; Gu W; Zheng L; Zhang Z
Clin Epigenetics; 2023 May; 15(1):92. PubMed ID: 37237385
[TBL] [Abstract] [Full Text] [Related]
15. DNA hypomethylation and upregulated
Wang X; Shen J; Wang L; Deng L; Bo H; Luo Y; Cui Y
Epigenomics; 2023 Mar; 15(5):293-306. PubMed ID: 37194576
[No Abstract] [Full Text] [Related]
16. Updated Salivary Gland Immunohistochemistry: A Review.
Swid MA; Li L; Drahnak EM; Idom H; Quinones W
Arch Pathol Lab Med; 2023 Dec; 147(12):1383-1389. PubMed ID: 37074867
[TBL] [Abstract] [Full Text] [Related]
17. [circ_0092315 Promotes Proliferation and Invasion of Papillary Thyroid Carcinoma Cells
Ke SH; Kong CX; Xu Y; Peng C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Feb; 45(1):16-21. PubMed ID: 36861149
[TBL] [Abstract] [Full Text] [Related]
18. CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis.
Tian T; Lu Y; Lin J; Chen M; Qiu H; Zhu W; Sun H; Huang J; Yang H; Deng W
Redox Biol; 2022 Dec; 58():102544. PubMed ID: 36427397
[TBL] [Abstract] [Full Text] [Related]
19. Salivary carcinosarcoma: insight into multistep pathogenesis indicates uniform origin as sarcomatoid variant of carcinoma ex pleomorphic adenoma with frequent heterologous elements.
Ihrler S; Stiefel D; Jurmeister P; Sandison A; Chaston N; Laco J; Zidar N; Brcic L; Stoehr R; Agaimy A
Histopathology; 2023 Mar; 82(4):576-586. PubMed ID: 36376255
[TBL] [Abstract] [Full Text] [Related]
20. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
Hu Y; Chen J; Liu M; Feng Q; Peng H
Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
[TBL] [Abstract] [Full Text] [Related]
[Next]
